Telangiectatic osteosarcoma of the femur in a young male.
DOI:
https://doi.org/10.51481/amc.v46i1.132Keywords:
Sarcoma, Sarcoma, hueso, hueso, radiología, radiología, osteoide , osteoide , quimioterapia, quimioterapia, gonalgia, gonalgiaAbstract
Telangiectatic osteosarcoma is a rare malignant lesion which constitutes about 2,5 % of all primary osteosarcomas. It has a more aggressive course than conventional osteosarcoma, as seen in large clinical series. By its clinical behavior, radiological and histopathological aspects, it is very similar to other benign tumors, such as aneurismatic bony cyst. We present here the case of a 24 year old male, with chronic pain in his left knee as only symptom. He was diagnosed with this rare form of osteosarcoma, amputated and then received a six month chemoteraphy regimen, after that, lung and thoracic wall metastasis were found. Therefore, recognition of this variant of osteosarcoma and its differentiation from benign lesions is important because resection alone carries poor prognosis, whereas if chemotherapy is added to the treatment plan the life expectancy improves. This condition should be kept in mind in the differential diagnosis of limb pain among young and healthy people .
Downloads
References
Rosai J. Bone and Joints. En: Mosby, ed . Ackerman's Surgical Pathology. 8 ed. St Louis, Missouri: 1996: 193645.
Nakajima H, Sim FH, Bond JR, Unni KK. Small cell osteosarcoma of bone. Review of 72 cases. Cancer 1997; 79(11): 2095106.
Huvos AG, Woodard HQ, Cahan WG, Bretsky SS. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer 1985; 55 (6): 12441255.
Tucker MA, Dángio GJ, Boice JD Jr, Lombardi F, Fraumeni JF Jr. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317(10): 588593.
Penman HG, Ring PA. Osteosarcoma in association with total hip replacement. J Bone Joint Surg (Br) 1984; 66 (5) : 632634
Cheng YS, Wright JM, Walstad WR, Finn MD. Osteosarcoma arising in Paget's disease of the mandible. Oral Oncol 2002 ;38(8):78592.
Merino S, Arrazola J, Saiz A; Blanco JA, Ortega L. Post paget telangiectatic osteosarcoma of the skull. Skeletal Radiol 1999; 28 (8): 470472.
Huvos AG, Sundaresan N, Bretsky SS, Butler A. Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer 1985; 56 (5): 12141221.
Parham DM, Prat CB, Parvey LS, Champion J. Chilhood multifocal osteosarcoma. Clinicopathologic and radiologic correlates. Cancer 1985; 55 (11): 26532658.
Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma in pregnant women. Prognosis, therapeutic implications, and literature review. Cancer 1985; 56 (9): 23262331.
Ayala AG, Ro JR, Raymond AK. Bone tumors. En: Mosby, ed. Anderson's Pathology. 10 ed. St Louis Missouri: 1996: 25312573.
Unni - Krishnan K. Bone Tumors. En: Lippincott Raven ,ed. Sternberg's Diagnostic Surgical Pathology. 2ed. New York:, 1994: 271322.
Huvos AG, Rosen G, Bretsky SS, Butler A .Telangiectatic OS: A clinicopathologic study of 124 patients. Cancer 1982; 49 (8): 16791689.
Mirra JM, Fain JS, Ward WG, Rosen G. Extraskeletal telangiectatic osteosarcoma. Cancer 1993; 71(10): 30143019.
Yamamoto T, Marui T, Mizuno K, Kizaki T, Hayashi Y . Anaplastic osteosarcoma with abundant eosinophilic cytoplasm and minimal osteoid production. Pathol Int 2000; 50(7):5537.
Park Y K, Joo M . Multicentric telangiectatic osteosarcoma. Case report. Pathol Int 2001; 51 (3): 200203
Whitehead RE, Melhem ER, Kasznica J, Eustace S. Telangiectatic Osteosarcoma of the skull base. Am J Neuroradiol 1998; 19 (4): 754757.
Mirra JM, Fain JS, Ward WG, Eckardt JJ, Eilber F, Rosen G. Extraskeletal telangiectatic osteosarcoma. Cancer 1993; 71(10):30149.
Bjornsson J, Inwards CY, Wold LE, Sim FH, Taylor WF. Prognostic significance of spontaneous tumour necrosis in osteosarcoma. Virchows Arch 1993; 423 (3): 195199.
Bacci G, Ferrari S, Mercuri M, Bertoni F, Picci P, Campanacci M. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 1998; 69 (3):2306.
Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Campanacci M. Longterm outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma2 protocol: an updated report. J Clin Oncol 2000 ;18(24):401627.
Bacci G, Ferrari S, Ruggieri P, Campanacci L, Bertoni F. Telangiectatic osteosarcoma of the extremity. Neoadjuvant chemotherapy in 24 cases. Acta Orthop Scand 2001; 72 (2):167172.
Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Kraus DH . Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 2002; 95(7): 1495503.
Bacci G, Bertoni F, Longhi A, Ferrari S, Forni C, Lari S. Neoadjuvant chemotherapy for highgrade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003 ;97 (12):306875.
Machak GN, Tkachev SI, Solovyev YN, Sinyukov PA, Ivanov SM, Glebovskaya VV. Neoadjuvant chemotherapy and local radiotherapy for highgrade osteosarcoma of the extremities. Mayo Clin Proc 2003; 78(2):14755.
Goor in AM, Schwartzentru be r DJ, Devida s M, Gebha rdt MC, Link MP. Presurgical chemother apy compar ed with immedi ate surgery and adjuva nt chemother apy for nonmetastatic osteos arcoma: Pedi atric Oncology Group Study POG8651. J Clin Oncol 2003; 21(8): 157480.
Antunes M, Bernardo J, Salete M, Prieto D, Tavares P. Excision of pulmonary metastases of osteogenic sarcoma of the limbs. Eur J Cardiothorac Surg 1999; 15(5): 5926.
Ferrari S, Bertoni F, Mercuri M, Picci P, Bacci G.Predictive factors of diseasefree survival for nonmetastatic osteosarcoma ofthe extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 2001 ;12(8):114550.
Bacci G, Longhi A, Ferrari S, Lari S, Versari M. Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep 2002; 9(1):1715
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
